To Survive After ICU Discharge

• Conditions: In-Hospital Mortality; Number of ICU Readmission; Number of Warnings On-duty

• Registration Number: NCT02599636
• Lead Sponsor: Althaia Xarxa Assistencial Universitària de Manresa

Brief Summary

Many factors before and after ICU stay determine the outcome of patients at ICU discharge, the type of illness, physical dependence and other sequelae can be a trigger for complications in hospital ward which can induce ICU readmission and worse outcome. The quality of medical assistance during all the hospitalisation should be guaranteed and many complications or fatal events could be avoidable.

The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.

Detailed Description

Material and Methods This observational multicenter study will be done in 21 medical-surgical ICUs. We will use Sabadell Score like prognostic scale at ICU discharge and the intensivist will collaborate with the medical team in medical assistance of patients at risk (Sabadell Score 1 and 2). Investigators will compare the hospital mortality and the readmission rate with a previous period when this collaboration didn't exist.

Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.

Study Timeline

• Study Start: 2015-10
• Study First Submitted: 2015-10-30
• Study First Submitted QC: 2015-11-05
• Study First Posted: 2015-11-06
• Status Verified: 2016-07
• Last Update Submitted: 2016-07-13
• Last Update Posted: 2016-07-14
• Primary Completion: 2016-09
• Study Completion: 2016-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

• All patients with Sabadell Score 1 (poor prognosis in long term) and 2 (poor prognosis in short term) at ICU discharge

Exclusion Criteria

• patients younger than 18 years old
• patients with Sabadell Score 0 (good prognosis)
• patients with Sabadell Score 3 (null expected survival)
• patients transferred to other hospitals

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The decline in hospital mortality	3 months

Secondary Outcome Measures

Name	Time	Method
The decline in number of warnings on-duty	3 months

Trial Locations

Locations (1)

Althaia Xarxa Assistencial Universitaria de Manresa; 🇪🇸 Manresa, Barcelona, Spain